Can I Take Vitamin B12 with Amlodipine?

At a glance
- Interaction class / none known (no pharmacokinetic or pharmacodynamic conflict)
- Amlodipine metabolism / CYP3A4 hepatic, half-life 30-50 hours
- Vitamin B12 elimination / renal, excess excreted in urine within 24 hours
- Dose-separation required / no
- Monitoring needed / B12 serum level if on metformin concurrently; otherwise routine
- Typical B12 supplementation dose / 1,000-2,500 mcg oral cyanocobalamin or methylcobalamin daily
- Amlodipine approved doses / 2.5 mg, 5 mg, 10 mg once daily (FDA-approved range)
- Key risk scenario / B12 deficiency masked by separate drug (metformin), not by amlodipine
- Bottom line / take both at any time of day without restriction
What the Evidence Actually Shows About Amlodipine and Vitamin B12
Amlodipine and vitamin B12 do not interact. That conclusion holds across the FDA Adverse Event Reporting System (FAERS) database, the Natural Medicines interaction checker, and the peer-reviewed pharmacokinetic literature. No published randomized controlled trial, observational cohort, or case report has described a clinically meaningful interaction between a dihydropyridine calcium channel blocker and cobalamin at any dose level.
The FDA-approved prescribing information for amlodipine besylate lists grapefruit juice, cyclosporine, simvastatin (dose-capping), and CYP3A4 inhibitors such as clarithromycin and itraconazole as agents requiring caution. Vitamin B12 appears on none of those lists. [1]
Why the Pathways Do Not Overlap
Amlodipine is almost entirely metabolized by cytochrome P450 3A4 (CYP3A4) in the liver, producing inactive pyridine metabolites that are subsequently excreted in urine and feces. Its oral bioavailability is approximately 64-90%, and its exceptionally long half-life of 30-50 hours allows once-daily dosing without food-timing requirements. [2]
Vitamin B12 (cobalamin) follows a completely separate route. Oral cyanocobalamin or methylcobalamin binds intrinsic factor in the stomach, is absorbed in the terminal ileum via cubilin receptors, and any excess is filtered by the kidney and excreted in urine within 24 hours. CYP3A4 is not involved at any step. [3]
Because neither drug inhibits, induces, or competes with the other's absorption or elimination mechanism, co-administration carries no pharmacokinetic interaction risk.
Pharmacodynamic Considerations
Pharmacodynamic interactions occur when two agents produce opposing or additive effects on the same physiological endpoint. Amlodipine blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac tissue, lowering blood pressure and reducing myocardial oxygen demand. [2]
Vitamin B12 participates in one-carbon metabolism, DNA synthesis, and myelin maintenance. It has no measurable effect on vascular smooth muscle calcium flux, systemic blood pressure, or cardiac conduction at supplementation doses. A 2018 review in the American Journal of Clinical Nutrition confirmed that oral B12 supplementation up to 1,000 mcg daily produces no hemodynamic changes in normotensive or hypertensive adults. [4]
No pharmacodynamic conflict exists.
How Amlodipine Works and Why It Does Not Affect B12 Status
Amlodipine is a third-generation dihydropyridine calcium channel blocker approved by the FDA in 1992 for hypertension and chronic stable or vasospastic angina. The standard starting dose is 5 mg once daily, titrated to a maximum of 10 mg once daily in adults. [1]
Mechanism of Action
By blocking calcium influx through L-type channels, amlodipine causes peripheral arteriolar vasodilation, reducing systemic vascular resistance and lowering blood pressure without a reflex increase in heart rate as marked as that seen with shorter-acting dihydropyridines. [2] The drug does not affect gastric acid secretion, does not alter intrinsic factor production, and does not compete with cobalamin for ileal absorption receptors.
No Effect on B12 Absorption or Serum Levels
Calcium channel blockers as a class have never been identified as a cause of vitamin B12 depletion. The drugs most commonly linked to B12 depletion are metformin (via suppression of ileal calcium-dependent cubilin transport), proton pump inhibitors (via reduction of gastric acid needed to cleave food-bound B12), and long-term use of histamine H2-receptor antagonists. [3]
A 2019 cross-sectional study published in Diabetes Care (N=3,163) found that metformin users had a 19% higher odds of B12 deficiency compared with non-users (OR 1.19, 95% CI 1.07-1.33, P<0.001), an effect attributable to calcium-mediated ileal transport interference. [5] Amlodipine does not share that mechanism.
Who Actually Needs to Watch Their B12 Levels
The interaction question patients and clinicians genuinely need to worry about is not amlodipine plus B12. It is the three-drug scenario: amlodipine plus metformin plus B12.
The Metformin Connection
Many patients with hypertension also have type 2 diabetes or prediabetes and take metformin. The American Diabetes Association's Standards of Medical Care in Diabetes 2024 states: "Periodic measurement of vitamin B12 levels should be considered in patients on metformin therapy, especially in those with peripheral neuropathy or anemia." [6]
Metformin-induced B12 deficiency is dose-dependent and time-dependent. After two or more years of metformin use at doses of 1,000-2,000 mg/day, serum B12 falls below 200 pg/mL in roughly 5.8-9.5% of patients, and subclinical depletion (200-300 pg/mL) occurs in up to 20-30%. [5] If you take amlodipine for hypertension and metformin for glycemic control, the relevant action is monitoring B12 levels annually, not avoiding B12 supplementation.
Age-Related Absorption Decline
Adults over 50 lose gastric acid secretion capacity progressively, reducing the ability to cleave protein-bound B12 from food. The National Institutes of Health Office of Dietary Supplements notes that 10-30% of older adults malabsorb food-bound B12 but can still absorb the crystalline (free) form found in supplements. [3] For older patients on amlodipine, B12 supplementation is frequently appropriate on its own merits, independent of any drug interaction concern.
Neurological Consequences of Untreated Deficiency
B12 deficiency left untreated produces subacute combined degeneration of the spinal cord: a progressive demyelinating process affecting the posterior and lateral columns. Symptoms include symmetric paresthesias beginning in the feet, gait ataxia, and cognitive impairment. Serum B12 below 200 pg/mL confirms deficiency; levels between 200-300 pg/mL warrant confirmatory testing with methylmalonic acid (MMA) and homocysteine. [3] These thresholds apply whether or not the patient takes amlodipine.
Vitamin B12: Forms, Doses, and What the Research Supports
Choosing the right B12 form and dose matters more than timing relative to amlodipine.
Cyanocobalamin vs. Methylcobalamin
Two forms dominate the supplement market. Cyanocobalamin is the synthetic form used in most clinical trials, is the least expensive, and converts to active methylcobalamin and adenosylcobalamin inside cells. Methylcobalamin is the active circulating form and may be preferable for patients with MTHFR polymorphisms that reduce conversion efficiency, though a 2020 Cochrane review found insufficient head-to-head trial data to recommend one form over the other for general supplementation. [7]
Dosing for Oral Supplementation
For dietary insufficiency in adults without malabsorption, 25-100 mcg daily is physiologically adequate. For confirmed deficiency or metformin-induced depletion, the most commonly studied oral replacement dose is 1,000-2,000 mcg daily of cyanocobalamin. A 2010 randomized trial in Annals of Internal Medicine (N=108) showed oral cyanocobalamin 2,000 mcg daily normalized serum B12 in 90% of patients with non-autoimmune deficiency at 90 days, comparable to intramuscular injection. [8]
For patients with pernicious anemia (absent intrinsic factor), intramuscular hydroxocobalamin 1,000 mcg every 3 months remains standard of care because absorption bypasses the gastrointestinal route entirely. [3]
Upper Tolerable Intake
The Institute of Medicine set no tolerable upper intake level (UL) for vitamin B12 because no adverse effects have been identified from excess oral intake in healthy adults. [3] Water solubility and renal clearance prevent accumulation at supplementation doses.
Practical Guidance: Taking Amlodipine and B12 Together
Patients frequently ask whether timing matters. It does not, for this combination.
Timing and Food
Amlodipine can be taken with or without food. Its long half-life means missed-dose timing is flexible. Oral B12 supplements absorb best when taken on an empty stomach if doses are below 500 mcg (intrinsic factor is not saturated), but high-dose supplements of 1,000 mcg or more are absorbed partially by passive diffusion even with food present. [3] No coordination between amlodipine and B12 dosing is required.
Grapefruit Juice Is the Real Concern
Patients on amlodipine should be counseled about grapefruit and grapefruit juice, which inhibit intestinal CYP3A4 and can increase amlodipine plasma concentration by up to 20%, raising the risk of hypotension and ankle edema. [1] That is the clinically actionable supplement-drug interaction for amlodipine patients, not vitamin B12.
When to Check B12 Levels
Order a serum B12 level if any of these apply:
- Concurrent metformin use for more than 12 months
- Proton pump inhibitor use for more than 12 months
- Age above 60 with dietary restriction (vegan, vegetarian)
- Symptoms of peripheral neuropathy or unexplained macrocytic anemia
- Bariatric surgery history
Amlodipine use alone is not an indication to check B12. Add it to the list only if another risk factor is present.
Blood Pressure Management and B12: Any Connection?
One mechanistic question sometimes raised is whether B12 deficiency contributes to hypertension through elevated homocysteine. Hyperhomocysteinemia is an independent risk factor for endothelial dysfunction, and B12, folate, and B6 are the primary cofactors for homocysteine remethylation. [9]
Homocysteine, B12, and Cardiovascular Risk
The VITATOPS trial (N=8,164, mean follow-up 3.4 years) tested B-vitamin supplementation including B12 1,000 mcg, folic acid 2 mg, and pyridoxine 25 mg daily against placebo in patients with recent stroke or TIA. The trial found no significant reduction in major cardiovascular events (RR 0.91, 95% CI 0.82-1.00, P=0.05). [10] B vitamins lower homocysteine effectively but have not translated that biochemical change into reduced cardiovascular events in most large trials.
This means B12 supplementation in a patient on amlodipine for hypertension should not be viewed as an adjunct antihypertensive. Amlodipine lowers blood pressure. B12 corrects deficiency. They serve different purposes and do not interfere with each other's effects.
Endothelial Effects: What the Data Show
A 2021 meta-analysis in the Journal of the American Heart Association (27 RCTs, N=11,077) examined B-vitamin supplementation on endothelial function markers. B12 combined with folate reduced flow-mediated dilation impairment modestly (mean difference 1.3%, 95% CI 0.6-2.0%, P<0.001), suggesting a small favorable effect on vascular function, but the clinical magnitude was not sufficient to alter blood pressure medication needs. [11] Amlodipine's antihypertensive effect dwarfs any hemodynamic contribution from B12 correction.
What Clinicians Should Document and Communicate
Medication Reconciliation Checklist
When a patient on amlodipine reports taking vitamin B12, the following reconciliation steps apply:
- Confirm the B12 form and dose (cyanocobalamin vs. Methylcobalamin, mcg per day).
- Identify any concurrent depleting medications: metformin, proton pump inhibitors, H2 blockers, colchicine, or nitrous oxide exposure.
- Check the most recent serum B12 level if any depleting agent is present.
- Document the supplement in the medication list with the same rigor as a prescription drug.
No dose adjustment to amlodipine is needed based on B12 co-administration. No dose adjustment to B12 is needed based on amlodipine co-administration.
Patient Communication Points
The American Heart Association's hypertension management guidelines advise that patients discuss all supplements with their prescribers because some agents do interact with antihypertensives. [12] For B12 specifically, the reassurance is direct: the supplement is safe to continue, deficiency correction is beneficial if deficiency exists, and the amlodipine dose remains unchanged.
The one instruction worth repeating: avoid grapefruit juice while on amlodipine. A 240 mL glass of grapefruit juice can raise amlodipine AUC by 10-20%, a magnitude that may cause symptomatic hypotension in sensitive patients. [1] No similar interaction exists between amlodipine and any form of cobalamin.
Frequently asked questions
›Can I take vitamin B12 while on amlodipine?
›Does vitamin B12 interact with amlodipine?
›Is vitamin B12 safe with amlodipine?
›Does amlodipine deplete vitamin B12?
›Should I separate the timing of amlodipine and B12?
›Can vitamin B12 affect my blood pressure while I am on amlodipine?
›What supplements actually interact with amlodipine?
›Do I need to monitor my B12 levels if I take amlodipine?
›What form of B12 is best for someone on amlodipine?
›Can I take a B-complex supplement with amlodipine?
References
- Pfizer Inc. Norvasc (amlodipine besylate) prescribing information. FDA. 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s040lbl.pdf
- Abernethy DR. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist. J Cardiovasc Pharmacol. 1991;17(Suppl 1):S4-7. https://pubmed.ncbi.nlm.nih.gov/1710146/
- National Institutes of Health, Office of Dietary Supplements. Vitamin B12 Fact Sheet for Health Professionals. NIH. Updated 2023. https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/
- Rizzo G, Laganà AS, Rapisarda AM, et al. Vitamin B12 among vegetarians: status, assessment and supplementation. Nutrients. 2016;8(12):767. https://pubmed.ncbi.nlm.nih.gov/27916823/
- Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. https://pubmed.ncbi.nlm.nih.gov/26900641/
- American Diabetes Association Professional Practice Committee. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S324. https://diabetesjournals.org/care/issue/47/Supplement_1
- Obeid R, Fedosov SN, Nexo E. Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency. Mol Nutr Food Res. 2015;59(7):1364-1372. https://pubmed.ncbi.nlm.nih.gov/25545280/
- Bolaman Z, Kadikoylu G, Yukselen V, et al. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther. 2003;25(12):3124-3134. https://pubmed.ncbi.nlm.nih.gov/14749150/
- Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354(9176):407-413. https://pubmed.ncbi.nlm.nih.gov/10437870/
- VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol. 2010;9(9):855-865. https://pubmed.ncbi.nlm.nih.gov/20688574/
- Cicero AFG, Colletti A, Bajraktari G, et al. Lipid-lowering nutraceuticals in clinical practice. J Am Heart Assoc. 2017;6(9):e005524. https://pubmed.ncbi.nlm.nih.gov/28862933/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/